Urethane Blog
Casper Files for IPO
January 10, 2020
Casper Sleep files for IPO
Well-known private mattress maker Casper Sleep has filed for its initial public offering.
It’s pointing to a “global sleep economy” of $432B as the opportunity, with $79B of that in the U.S. and a global compound annual growth rate of 6.3%. It’s filed for a placeholder sum of $100M.
The company’s not profitable yet, but growing rapidly. For the nine months ended Sept. 30, it logged revenue of $312M (up 20% Y/Y) and an operating loss of $65.1M (roughly flat). With most expenses tied up in sales/marketing and G&A, net loss was $67.4M for that period vs. a prior-year loss of $64.2M.
It’s seeking to list on NYSE under the symbol CSPR.
The company was valued post-money at $1.1B last year, after investments from companies including Target (TGT +1.1%).
As competitors, it faces mostly legacy mattress makers (including Tempur Sealy (TPX +0.3%), Serta Simmons and Sleep Number (SNBR +1.4%)) along with more recent direct-to-consumer entrants like Purple and Leesa.
The filing comes via Morgan Stanley, Goldman Sachs, Jefferies, BofA Securities, UBS Investment Group, Citigroup, Piper Sandler and Guggenheim.
https://seekingalpha.com/news/3531059-casper-sleep-files-for-ipo?utm_medium=email&utm_source=seeking_alpha#email_link
See the IPO filing with the SEC here:
https://www.sec.gov/Archives/edgar/data/1598674/000104746920000166/a2240404zs-1.htm
Sign Up for Email Updates
Everchem Updates Archive
Recent News
July 18, 2024
July 11, 2024
July 9, 2024